Connect Sign In
ARUP presented key molecular pathology advancements at AMP 2024 on topics such as viral load prediction, automated DNA extraction, and parasite detection.
A new, first-of-its-kind test uses blood-based biomarkers to assess the risk of developing preeclampsia with severe features and facilitates appropriate interventions.
Benjamin T. Bradley, MD, PhD, was awarded a grant to study the use of a self-collection blood sample device to increase access to hepatitis C virus testing in rural Utah counties.
ARUP medical directors will present at the 2024 Association of Medical Laboratory Immunologists (AMLI) Annual Meeting on emerging topics in the field.
The new Sherrie Perkins Research and Innovation Collaboration Grant, designed to foster collaboration in healthcare, will fund cutting-edge research in lab medicine that could impact patient care.
ARUP experts will present at ASM Microbe 2024 on emerging topics in infectious disease, including parasitology, mycobacterial infections, and more.
Nearly 85% of respondents to an ARUP survey believe the FDA’s proposed rule to regulate lab-developed tests will negatively impact their labs. Only 3% believe they have the financial resources to
ARUP medical directors and scientists will discuss the latest in pharmacogenomics, RNA sequencing, and laboratory genetics career pathways at the upcoming ACMG Annual Clinical Genetics Meeting.
Researchers at ARUP Laboratories published more than 130 peer-reviewed articles and contributed more than 135 posters or presentations at medical conferences in FY2023 to advance laboratory medicine.
ARUP experts in molecular pathology will present at, participate in, and be available to attendees during the upcoming Association for Molecular Pathology (AMP) Meeting and Expo in Salt Lake City.
The Association for the Advancement of Blood and Biotherapies recommends that providers use a restrictive transfusion strategy to reduce unnecessary transfusions and the risk of adverse events.
ARUP and Gestalt Diagnostics announced a partnership under which ARUP will adopt Gestalt’s PathFlow® platform as a foundation for future digital pathology initiatives.
